VALIDATE Fellowships: Vaccine R&D for complex intracellular pathogens causing disease in LMIC. Deadline 8 April 2024
About
The University of Oxford, as part of its VALIDATE Network, invites applications for its fellowships. These aim to accelerate vaccine research and development for three groups of complex neglected intracellular pathogens that cause significant mortality and morbidity throughout the world, particularly in low-and-middle-income countries (LMICs): Mycobacteria (causing tuberculosis, leprosy and other diseases), Leishmania (causing leishmaniasis) and Burkholderia pseudomallei (causing melioidosis). A second, important aim of the VALIDATE Network is to facilitate career progression for its members, particularly Early Career Researchers (ECRs), and (recognising career progression inequity) researchers from LMICs and researchers identifying as female and/or non-binary.
The VALIDATE Fellowships will fund two years’ independent scientific research, with the aim of producing initial/pilot data and a funding and experience track record that can be used by the Fellow to go on to obtain independent external funding and launch their career as a Principal Investigator and/or Group Leader.
This call is repeated every 3 years.
AMOUNT
Maximum total budget is:
- For LMIC-based members: £100,000
- For HIC-based members: £150,000 (acknowledging higher salary costs)
Fellowships should run for 24 months.
ELIGIBILITY
Applicants must:
- Be an Associate member of VALIDATE
- Not have received a prior VALIDATE Fellowship
Any aspect of research that will accelerate development of an efficacious vaccine for our focus pathogens is eligible, including biological, physical and social sciences, and humanities. VALIDATE offer additional support to LMIC applications – see the VALIDATE website for details.